Startup AI Diagnostics showcased its tuberculosis monitor at MWC 2026, which could one day scan for other lung- and heart-related diseases.
HOUSTON, Feb. 16, 2026 /PRNewswire/ -- New data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) from the NRG/NSABP B-42 trial demonstrated that the Endocrine Activity Index (EAI) ...
Delphi Diagnostics' Endocrine Activity Index® (EAI™) test can provide actionable information for prognosis and prediction of dose-intense taxane-based chemotherapy benefit in stage II-III, HR+ HER2- ...
REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ — The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic ...